NCT02436850

Brief Summary

The purpose of the trial is to evaluate the effectiveness of moderate to large volume thoracentesis (TC) in non-ventilated patients in Internal Medicine admitted due to, or suffer from respiratory instability. This is a prospective, double-center, randomized clinical trial. This is a stage 1 pilot trial aimed to provide better understanding on the study population and study groups. This trial will comprise a total of 60 patients, 30 subjects on the intervention group and an equal number on the control group. The results of this pilot trial will be to design a larger trial and calculate a required sample size.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 7, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

March 16, 2016

Status Verified

March 1, 2016

Enrollment Period

1 year

First QC Date

April 20, 2015

Last Update Submit

March 15, 2016

Conditions

Keywords

ThoracentesisPocket Ultrasound DeviceUltrasoundSoroka University Medical CenterPhysical ExaminationEthical Committee

Outcome Measures

Primary Outcomes (1)

  • Hospital length of stay

    12 months

Secondary Outcomes (2)

  • Vital signs and wellbeing questionnaire

    12 months

  • Readmission rates

    12 months

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will receive large volume thoracentesis.

Procedure: Thoracentesis

Control group

NO INTERVENTION

The control group will be taped with an 18 gauge and 20 gauge venflons and drain will not be placed.

Interventions

ThoracentesisPROCEDURE

An invasive procedure to remove fluid or air from the pleural space for diagnostic or therapeutic purposes.

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to internal ward
  • Patients with moderate to large pleural effusion per ultrasound as defined under Eligibility section below
  • At least of the following findings:
  • Dyspnea on admission notes
  • Tachypnea (RR \>18 pm)
  • Desaturation (saturation\<88%)
  • Admission diagnosis of CHF exacerbation or any uncontrolled heart failure,
  • Effort dyspnea per history,
  • Acute or subacute (last two weeks) need for oxygen supplement or Noninvasive ventilation.
  • Admission diagnosis of pulmonary edema or pulmonary congestion
  • Hypoxemia (PaO2\<60mmHg)
  • Pleuritic chest pain

You may not qualify if:

  • Subject currently enrolled in another investigational study
  • Patients on mechanical ventilation
  • Patients with coagulopathy (known or with any prolongation of PTT, PT, fibrinogen\<200, platelets \<100000)
  • Patients with cognitive impairment who cannot sign informed consent
  • Patients with sepsis or fever and pneumonia and suspected empyema
  • Patients with any previous surgeries to the lungs
  • Patients whom the primary team call for therapeutic TC.
  • Patients with less than moderate amount of pleural effusion (see Eligibility criteria)
  • Palliative patients
  • Pregnant patients
  • On any current anticoagulation therapy or with any abnormal coagulation study.
  • Patients with septations or cavitation in pleural space (visible on US

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Soroka University Medical Center

Beersheba, Israel

RECRUITING

Related Publications (14)

  • Fartoukh M, Azoulay E, Galliot R, Le Gall JR, Baud F, Chevret S, Schlemmer B. Clinically documented pleural effusions in medical ICU patients: how useful is routine thoracentesis? Chest. 2002 Jan;121(1):178-84. doi: 10.1378/chest.121.1.178.

    PMID: 11796448BACKGROUND
  • Mattison LE, Coppage L, Alderman DF, Herlong JO, Sahn SA. Pleural effusions in the medical ICU: prevalence, causes, and clinical implications. Chest. 1997 Apr;111(4):1018-23. doi: 10.1378/chest.111.4.1018.

    PMID: 9106583BACKGROUND
  • Walden AP, Garrard CS, Salmon J. Sustained effects of thoracocentesis on oxygenation in mechanically ventilated patients. Respirology. 2010 Aug;15(6):986-92. doi: 10.1111/j.1440-1843.2010.01810.x. Epub 2010 Jul 20.

    PMID: 20646244BACKGROUND
  • Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest. 1987 Jun;91(6):817-22. doi: 10.1378/chest.91.6.817.

    PMID: 3581930BACKGROUND
  • Wang LM, Cherng JM, Wang JS. Improved lung function after thoracocentesis in patients with paradoxical movement of a hemidiaphragm secondary to a large pleural effusion. Respirology. 2007 Sep;12(5):719-23. doi: 10.1111/j.1440-1843.2007.01124.x.

    PMID: 17875061BACKGROUND
  • Estenne M, Yernault JC, De Troyer A. Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. Am J Med. 1983 May;74(5):813-9. doi: 10.1016/0002-9343(83)91072-0.

    PMID: 6837605BACKGROUND
  • Jones PW, Moyers JP, Rogers JT, Rodriguez RM, Lee YC, Light RW. Ultrasound-guided thoracentesis: is it a safer method? Chest. 2003 Feb;123(2):418-23. doi: 10.1378/chest.123.2.418.

    PMID: 12576360BACKGROUND
  • Perazzo A, Gatto P, Barlascini C, Ferrari-Bravo M, Nicolini A. Can ultrasound guidance reduce the risk of pneumothorax following thoracentesis? J Bras Pneumol. 2014 Jan-Feb;40(1):6-12. doi: 10.1590/S1806-37132014000100002.

    PMID: 24626264BACKGROUND
  • Eibenberger KL, Dock WI, Ammann ME, Dorffner R, Hormann MF, Grabenwoger F. Quantification of pleural effusions: sonography versus radiography. Radiology. 1994 Jun;191(3):681-4. doi: 10.1148/radiology.191.3.8184046.

    PMID: 8184046BACKGROUND
  • Lichtenstein D, Hulot JS, Rabiller A, Tostivint I, Meziere G. Feasibility and safety of ultrasound-aided thoracentesis in mechanically ventilated patients. Intensive Care Med. 1999 Sep;25(9):955-8. doi: 10.1007/s001340050988.

    PMID: 10501751BACKGROUND
  • Balik M, Plasil P, Waldauf P, Pazout J, Fric M, Otahal M, Pachl J. Ultrasound estimation of volume of pleural fluid in mechanically ventilated patients. Intensive Care Med. 2006 Feb;32(2):318. doi: 10.1007/s00134-005-0024-2. Epub 2006 Jan 24.

    PMID: 16432674BACKGROUND
  • Vignon P, Chastagner C, Berkane V, Chardac E, Francois B, Normand S, Bonnivard M, Clavel M, Pichon N, Preux PM, Maubon A, Gastinne H. Quantitative assessment of pleural effusion in critically ill patients by means of ultrasonography. Crit Care Med. 2005 Aug;33(8):1757-63. doi: 10.1097/01.ccm.0000171532.02639.08.

    PMID: 16096453BACKGROUND
  • Roch A, Bojan M, Michelet P, Romain F, Bregeon F, Papazian L, Auffray JP. Usefulness of ultrasonography in predicting pleural effusions > 500 mL in patients receiving mechanical ventilation. Chest. 2005 Jan;127(1):224-32. doi: 10.1378/chest.127.1.224.

    PMID: 15653988BACKGROUND
  • Feller-Kopman D, Walkey A, Berkowitz D, Ernst A. The relationship of pleural pressure to symptom development during therapeutic thoracentesis. Chest. 2006 Jun;129(6):1556-60. doi: 10.1378/chest.129.6.1556.

    PMID: 16778274BACKGROUND

MeSH Terms

Interventions

Thoracentesis

Intervention Hierarchy (Ancestors)

ParacentesisSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesTherapeuticsSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Ori Galante

Study Record Dates

First Submitted

April 20, 2015

First Posted

May 7, 2015

Study Start

August 1, 2015

Primary Completion

August 1, 2016

Study Completion

August 1, 2017

Last Updated

March 16, 2016

Record last verified: 2016-03

Locations